• Anabolic hormone topical skin cream
• Skin enzymes convert 1-Androsterone™ to 1-Testosterone
• Skin enzymes convert DHEA to Androstenediol & Testosterone
• Produces rapid gains in lean muscle mass and strength
• Non-methylated - Non-toxic to the liver - Low estrogen conversion

For information about the active ingredients in 1-T, please visit the 1-T Liqua-Vade page.

1. Administer lotion every morning, after a shower
2. Administer 4-5 pumps and apply to the skin*
3. Allow 4-5 minutes to dry

*Apply to shoulders and upper-back for best conversion

Only apply the product to clean, dry skin. Shaving off body hair is recommended, but not required. Also, avoid swimming, bathing or tanning for at least 6 hours after application.

             $195.95               $232.95            

1. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.

A Friedel, et al.
Toxicol Lett, Aug 2006; 165(2): 149-55.

2. Galletti and Gardi, “Metabolism of 1-Dehydroandrostanes in Man” 
J Steroid Biochem, 3 (1972), 933-936

3. Chen G, Bourneuf E, Marklund S, Zamaratskaia G, Madej A, Lundström K. Gene expression of 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase in relation to androstenone, testosterone, and estrone sulphate in
gonadally intact male and castrated pigs.
J Anim Sci. 2007 Oct;85(10):2457-63.

4. The metabolism of [4-14C] 5 androstene-3P, 17P-diol by normal human skin in vitro. 
Faredin, et al. 
Acta Med. Acad. Sci. Hung. 32:139. 1975.

5. Sebocytes are the key regulators of androgen homeostasis in human skin. 
M Fritsch, et al.
J Invest Dermatol, May 1, 2001; 116(5): 793-800.

6. The formation of water soluble steroids by human skin. 
Berliner, D. L., et al.
J. Invest. Dermatol. 50:220. 1968

7. The metabolism of [4-14C] dehydroepiandrosterone by human skin in vitro. I. Transformation in vitro of [4-14C] dehydroepiandrosterone into Androst-4-ene-3,17-dione, testosterone and androsterone by normal human male and female skin slices. 
I Faredin, et al. 
Acta Med Acad Sci Hung, Jan 1970; 27(1): 95-102.

8. Activity and inhibition of 3-beta-hydroxysteroid dehydrogenase/delta-5-4-isomerase in human skin.
Skin Pharmacol. 1997;10(3):160-8.

9. Transformation and conjugation of dehydroepiandrosterone by human skin. 
Berliner, D. L., et al. 
J. Clin. Endocrinol. 27:1214. 1967.

10. The in vitro metabolism of dehydroepiandrosterone in human skin. 
I Faredin, et al. 
Acta Med Acad Sci Hung, Jan 1967; 23(2): 169-79.

11. Effects of transdermal application of DHEA to men on the levels of steroids, gonadotropins and lipids. 
SULCOV� J, et al.
Physiol Res 49: 685-693, 2000.

12. Transformation in vitro of [4-14C ] dehydroepiandrosterone into 7-oxygenated derivatives by the normal human male and female skin tissue. 
Faredin, I., et al.
J. Invest. Dermatol. 52:357. 1969

13. Pharmacokinetics of a new testosterone transdermal delivery system, TDS-testosterone in healthy males.
Z Chik, et al.
Br J Clin Pharmacol, Mar 2006; 61(3): 275-9.

14. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat 
C Labrie, et al. 
Sep 1996; 150: S107 - S118.

15. Androstenediol reduces the anti-inflammatory effects of restraint stress during wound healing. 
CC Head, et al. 
Brain Behav Immun, Nov 2006; 20(6): 590-6.

16. Androstenetriol improves survival in a rodent model of traumatic shock. 
AC Marcu, et al. 
Resuscitation, December 1, 2006; 71(3): 379-86.

17. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. 
Morales AJ, et al.
J Clin Endocrinol Me tab 1994;78:1360- 1367.